WOOLCOCK emphysema CENTRE 

Welcome to Australia's only research centre dedicated to the fight against chronic obstructive pulmonary disease (COPD). The high-tech facility leads the way with research to better understand, treat and prevent this disease which includes emphysema and chronic bronchitis. 

The establishment of the Woolcock Emphysema Centre has been made possible through the generous support of our Donors, the Ernest Heine Family Foundation, and Mrs Janice Gibson and the late Mr Freddie Gibson.

Emphysema is one of the most important components of COPD. The World Health Organisation (WHO) reports COPD to affect more than 80 million people globally, making it the third most common cause of death. COPD accounted for more than three million deaths in 2012 and the WHO predicts a 30% increase in mortality between 2005 and 2020. Nationally, respiratory diseases including COPD affect 1 in 4 Australians (6 million people) with a government cost of more than $1 billion per year.